Provectus Biopharmaceuticals, Inc. (PVCT)
Market Closed
30 Jul, 20:00
OTC PINK OTC PINK Primary 
XSTU $
0. 06
-0
-5.8064%
$
26.06M Market Cap
- P/E Ratio
- Div Yield
28,200 Volume
0 Eps
$ 0.06
Previous Close 
Want to track PVCT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Provectus Biopharmaceuticals, Inc. (PVCT) Shareholder/Analyst Call Transcript
Provectus Biopharmaceuticals, Inc. (PVCT) Shareholder/Analyst Call Transcript
Seekingalpha | 1 month ago
Provectus Biopharmaceuticals, Inc. (PVCT) Q4 2024 Earnings Call Transcript
Provectus Biopharmaceuticals, Inc. (OTC:PVCT) Q4 2024 Results Conference Call November 14, 2024 2:00 PM ET Company Participants Alyssa Barry - Co-Founder & Principal of Investor Relations, Alliance Advisors IR Ed Pershing - Chairman Dominic Rodrigues - Board Vice Chairman Alyssa Barry Good afternoon, good morning, good evening, depending on where you are. Welcome to Provectus Biopharmaceuticals Fourth Quarter Investor Update.
Seekingalpha | 1 year ago
